INFO:

: An investigational mRNA vaccine used along with immunotherapy continues to show benefit for people with high-risk forms of the skin cancer melanoma, the drugmakers said Thursday. CNN's Paula Newton discusses the drug with professor Georgina Long from Melanoma Institute Australia.